openPR Logo
Press release

Over the Counter (OTC) Drugs Market to Grow at an Impressive Rate of 9.86% During Forecast Period | TechSci Research

11-30-2021 07:09 AM CET | Health & Medicine

Press release from: TechSci Research LLC

Global Over the Counter Drugs Market - TechSci Research

Global Over the Counter Drugs Market - TechSci Research

Growth in awareness related to general health concerns is expected to drive the growth of global over the counter (OTC) drugs market.

According to TechSci Research report, “Global Over the Counter (OTC) Drugs Market By Product (Cough, Cold & Flu, Vitamins, Mineral, & Supplements (VMS), Analgesics, Gastrointestinal Products, Dermatology Products, Others), By Route of Administration (Oral, Parenteral, Topical, Others), By Dosage Form (Tablets, Capsules, Liquids & Solutions, Cream/Lotion/Ointments, Others), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy), By Region, Competition, Forecast & Opportunities, 2026”, Global Over the Counter (OTC) drugs market stood at USD154.01 billion in 2020 and is expected to grow at a CAGR of around 9.86% during the forecast period. This can be ascribed to the growing prevalence of various chronic diseases such as diabetes, cancer, cardiovascular diseases, renal disorders, among others.

This has, in turn, increased the patient pool worldwide, thereby positively influencing the market growth through 2026. Additionally, growing awareness regarding general health concerns and advancements in the healthcare industry is further expected to support the market growth over the next few years. However, the influx of new innovative drugs for the treatment of various diseases can restrict market growth over the next few years. Furthermore, the lack of seamless reclassification of drugs from prescription medicines to over-the-counter drugs can restrict the market growth during the forecast period. Besides, substance abuse and lesser awareness can further slowdown the market growth over the next few years.

Browse 143 Figures spread through 110 Pages and an in-depth TOC on "Global Over the Counter (OTC) Drugs Market "
https://www.techsciresearch.com/report/over-the-counter-drugs-market/5054.html

Global over the counter (OTC) drugs market can be segmented based on product, route of administration, dosage form, distribution channel, region, and company. Based on distribution channel, the market can be categorized into retail pharmacy, hospital pharmacy and e-pharmacy. The retail pharmacy segment dominated the market with an overall share of 52.69% on account of various benefits associated with retail pharmacies, such as convenience, easy availability, among others. The e-pharmacies segment is expected to register the highest growth during the forecast period on account of the widespread penetration of various e pharmacies worldwide.

Johnson & Johnson, Bayer AG, Novartis AG, GlaxoSmithKline Plc.-Pfizer, Inc., Sanofi S.A., Perrigo Company Plc., Reckitt Benckiser Group Plc., Sun Pharmaceutical Industries Ltd., The Procter & Gamble Company, Teva Pharmaceutical Industries Limited, Dr. Reddy’s Laboratories Ltd., Zydus Takeda Healthcare Pvt. Ltd., Mylan NV, Cipla Ltd., Alkem Laboratories Limited, among others. The various players operating in the market are adopting strategies such as product launches, mergers & acquisitions, among others to stay competitive in the market and have an edge over the other players operating in the market.

Download sample report @ https://www.techsciresearch.com/sample-report.aspx?cid=5054
Customers can also request for 10% free customization on this report.

“Asia-Pacific region is anticipated to register the highest growth in the global over the counter (OTC) drugs market during the forecast period on account of growing focus of pharmaceutical companies in the region to develop over the counter drugs especially in countries like India and China. Furthermore, growing awareness pertaining to maintaining a healthy lifestyle has shifted the focus of the population residing in the region towards various over the counter vitamin and mineral supplement products, thereby supporting market growth.”, said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.

“Global Over the Counter (OTC) Drugs Market By Product (Cough, Cold & Flu, Vitamins, Mineral, & Supplements (VMS), Analgesics, Gastrointestinal Products, Dermatology Products, Others), By Route of Administration (Oral, Parenteral, Topical, Others), By Dosage Form (Tablets, Capsules, Liquids & Solutions, Cream/Lotion/Ointments, Others), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy), By Region, Competition, Forecast & Opportunities, 2026” has evaluated the future growth potential of global over the counter (OTC) drugs market and provides statistics and information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in global over the counter (OTC) drugs market.

Browse Related Reports:
Global Oncology Drugs Market By Drug Type (Cytotoxic Drugs, Targeted Drugs, Hormonal Drugs), By Therapy (Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy, Others), By Drug Therapy (Adjuvant, Neoadjuvant and Concurrent), By Route of Administration (Oral, Intravenous, Subcutaneous, Others), By Gender (Male, Female), By Cancer Type (Lung Cancer, Stomach Cancer, Others), By Distribution Channel (Hospital Pharmacies, Others), By Region, Competition, Forecast & Opportunities, 2025
https://www.techsciresearch.com/report/oncology-drugs-market/4689.html

Global Consumer Healthcare Market By Product (Over-the-Counter Drugs (OTC); Vitamins and Dietary Supplements; Herbal/Traditional Products; Sports Nutrition; and Others), By Distribution Channel (Modern Grocery Retail; Traditional Grocery Retail; Non-Grocery/Mixed Retailers; Non-store-based Retail; and Others), By Region, Forecast & Opportunities, 2025
https://www.techsciresearch.com/report/consumer-healthcare-market/4680.html

About TechSci Research:
TechSci Research is a leading global market research firm publishing premium market research reports. Serving 700 global clients with more than 600 premium market research studies, TechSci Research is serving clients across 11 different industrial verticals. TechSci Research specializes in research-based consulting assignments in high growth and emerging markets, leading technologies and niche applications. Our workforce of more than 100 fulltime analysts and consultants employing innovative research solutions and tracking global, and country specific high growth markets helps TechSci clients to lead rather than follow market trends.

Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: sales@techsciresearch.com
Website: https://www.techsciresearch.com/
For More Market Research Blogs Visit: https://techsciblog.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Over the Counter (OTC) Drugs Market to Grow at an Impressive Rate of 9.86% During Forecast Period | TechSci Research here

News-ID: 2478889 • Views: 131

More Releases from TechSci Research LLC

United States Medical Aesthetic Devices Market to Grow with an Impressive CAGR u …
Technological advancement is driving the growth of United States Medical Aesthetic Devices Market, in the forecast period. According to TechSci report on, “United States Medical Aesthetic Devices Market By Type of Device (Energy-Based Aesthetic Device {Laser-Based Aesthetic Device, Radiofrequency-Based Aesthetic Device, Light-Based Aesthetic Device, Others} v/s Non-Energy-Based Aesthetic Device {Aesthetic Botulinum Toxin, Microdermabrasion, Implants, Others}) By Application (Skin Resurfacing and Tightening, Body Contouring and Cellulite Reduction, Hair Removal, Facial Aesthetic Procedures,
Lithotripsy Devices Market to Grow with Double Digit CAGR During the Forecast Pe …
Rising cases of kidney stones is driving the growth in Global Lithotripsy Devices Market in the forecast period, 2022-2026. According to TechSci Research report, “Global Lithotripsy Devices Market By Type (Intracorporeal Lithotripsy, Extracorporeal Shock Wave Lithotripsy (ESWL)) By Modality (Standalone v/s Portable) By Application (Kidney Stone, Pancreatic Stones, Ureteral Stones, Bile Duct Stone) By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Others) By Region, Competition Forecast & Opportunities, 2026”, the
Anesthesia Monitoring Devices Market to Grow with an Impressive CAGR During the …
Advancing technology in medicine is driving the growth in Global Anesthesia Monitoring Devices Market in the forecast period, 2022-2026. According to TechSci Research report, “Global Anesthesia Monitoring Devices Market By Product Type (Basic Anesthesia Monitors, Advanced Anesthesia Monitors, Integrated Anesthesia Workstation) By End User (Hospitals & Surgical Centers, Ambulatory Care Centers, Others) By Region, Competition Forecast & Opportunities, 2026”, the global anesthesia monitoring devices market is expected to show a robust
Why are Major Conglomerates Suddenly Splitting Up into New Corporate Entities? | …
There has been a crazy new trend of ginormous global companies dismantling into multiple entities as diversification isn’t a rage in the corporate world. Companies like Johnson & Johnson, GE, Pfizer, Merck, GlaxoSmithKline have recently announced their corporate divorces, but the splits are not confined to the healthcare sector. Many tech giants, global retail brands, telecom companies have spun off large divisions so that they can invest their time and

All 5 Releases


More Releases for Drug

Biologics Drug Discovery Market
2019-2025 Biologics Drug Discovery Market Report with Depth Analysis The biologics drug discovery involves target identification, hit-to-lead stage, lead identification and optimization. The report presents a comprehensive overview, market size, shares, and growth opportunities of Biologics Drug Discovery market by product type, application, key manufacturers and key regions. Request For Free report Sample -https://www.reportsmonitor.com/request_sample/306320 Scope of the Report: Furthermore, Biologics Drug Discovery Market report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers or
Opioid Antagonist Drug Market
The global market has been prognosticated to earn demand from popular types of products such as external use, oral and applications such as household and hospital. The Company has made available another publication in its Healthcare archive of market intelligence reports, which is titled “Global Opioid Antagonist Drug Market Research Report 2018.” While the threat of substitutes and technological risks could have an unfavorable impact on the global market, potential
Drug and cosmetics
Drug and Cosmetics Conferences regards each one of the individuals to go to the On “Drug and Cosmetics” amidst October 17-October 18, 2018 in Toronto, Canada which melds brief keynote presentations, speaker talks, Exhibition, Symposia, Workshops. Drug and Cosmetics Congress is one of the meetings and conferences which will be visited by all the prestigious cosmetologists, Scientists, fiery inspectors, postgraduates, affiliations, business meanders under a solitary rooftop. DRug and cosmetics BLESSY MATHEW Program
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning